Strongyloidiasis
ICD-10 B78 · ICD-11 1F6B

Treatment of Strongyloidiasis in Hyperinfection Syndrome or Disseminated Disease

Hyperinfection syndrome and disseminated strongyloidiasis represent the most severe presentations of Strongyloides infection. These situations require prompt, structured management guided by a specific clinical protocol.

Clinical Scenario

This protocol is indicated for patients presenting with hyperinfection syndrome or disseminated strongyloidiasis — a high-acuity situation requiring urgent and systematic clinical intervention.

Treatment Approach

Where clinically feasible, the approach involves reduction or cessation of immunosuppressive therapy, combined with antiparasitic treatment with ivermectin. The appropriate route of administration is determined by the patient's clinical condition and their ability to tolerate therapy.

Dosing, route selection criteria, and the complete treatment algorithm are specified in the full protocol.

Treatment Goal

Confirmed clearance of Strongyloides, demonstrated by negative stool and/or sputum examinations.

References

  • Hyperinfection syndrome/Disseminated strongyloidiasis
  • If possible, immunosuppressive therapy should be stopped or reduced, and antiparasitic treatment initiated.
View source ↗